Figure 1
(A) Treatment allocation of the entire hepatocellular carcinoma cohort. (B) Patients stratified by HCV infection, DAA therapy, and achievement of SVR12.
Figure 1 | Scientific Reports
(A) Treatment allocation of the entire hepatocellular carcinoma cohort. (B) Patients stratified by HCV infection, DAA therapy, and achievement of SVR12.
